Victory Square Technologies (CANADA: VST) (U.S.: VSQTF) (EUROPE: 6F6) is involved in industries ranging from Blockchain to AR/VR, gaming to cybersecurity, renewable energy, and more. Most recently? The company has announced the official launch of its new Telehealth business platform, DiscreetCare.
DiscreetCare is a part of VST’s multi-phase expansion into the continuously growing Telehealth sector.
What does DiscreetCare do?
Prioritizing the confidentiality of sensitive health issues, DiscreetCare runs from an app that offers treatments and at-home testing for a select number of… sensitive conditions.
As more and more people become comfortable receiving medical care from their own home, Telehealth has gone from being an early-stage category, to a staple across the U.S.
Doing what they do best, VST has positioned themselves to capitalize on this innovative trend. With the potential to provide a one-stop solution for businesses that seek a white-label virtual care platform and clinician network, this opportunity is strategic in multiple ways; not to mention that DiscreetCare can significantly enhance the niche services that VST provides.
Its primary focus, as it establishes its foothold in the U.S., is split into 2 phases.
Phase 1 – DiscreetCare.com focuses on treating symptoms such as:
- Hair Loss,
- Erectile Dysfunction,
- Premature Ejaculation,
- Genital Herpes,
- Cold Sores,
- Acne, and
- Bladder Control Issues.
Phase 2 – The web app will offer treatment for a broader range of delicate medical issues, and at-home testing for conditions such as:
- STDs,
- Testosterone, and
- Fertility.
Victory Square Technologies CEO, Shafin Diamond Tejani said, “The vision for DiscreetCare is to be a one-stop provider for what many consider ‘delicate’ medical issues. Our web app gives users access to testing, treatment and prescriptive medicinal remedies – all from the convenience and privacy of one’s mobile device.”
In lieu of the traditional method of seeing a doctor at a clinic, DiscreetCare offers a much more… discreet way of booking appointments.
1) Login to to DiscreetCare.com using your computer or mobile device.
2) Answer a series of medical questions which will be reviewed by a licensed physician.
3) Receive your medication in discreet packaging within 2 to 4 days.
4) Follow-up with your doctor, pharmacist or DiscreetCare support if you have any additional questions or concerns.
With doctors across all 50 states, private virtual appointments are readily available with the vast network of physicians DiscreetCare has.
Additional benefits such as doctor evaluations and competitively priced FDA-approved medications are also included in the offerings of DiscreetCare.
VS Digital Health Vice President of Marketing, Binu Koshy, explains, “By offering a service that is both discreet and convenient, we are providing healthcare solutions to those who until now, have chosen ‘avoidance’ over action when it comes to their overall wellbeing. Koshy adds, “Think of that 20-something who just started losing his hair but is too embarrassed to seek treatment, or that 30-year-old with Erectile Dysfunction (ED) who avoids seeking important medical offerings because the Viagra and Cialis commercials typically show and sell to men who are 20 years older.”
You would be surprised at how many people suffer from the issue of avoidance when it comes to their health. Conditions that may bring out feelings of embarrassment often delay or prevent those afflicted from seeking help.
The traditional act of booking an appointment, sitting in a public waiting room, and having a face-to-face conversation with a physician can ignite awkwardness and act as a roadblock to one’s own physical health.
Hence why socially stigmatized conditions, or any condition that is potentially discomforting to speak about, are the objects of DiscreetCare’s focus.
Corporate Update
2020 proved to be a rather important inflection point for VST, as the company was on the verge of being ultimately profitable, with 2021 following suit as the company successfully masters the art of monetizing the incubation of innovative and disruptive early-stage companies.
A quick highlight reel from the latest period ending on May 31, 2021.
- Net income for the fiscal year of 2020 was C$19,733,031. Earnings Per Share (EPS) was $0.30. The entire 2020 fiscal year consisted of 4 consecutive quarters of positive net income.
- GameOn Entertainment Technologies, and Immersive Tech both announced oversubscribed financings.
- VST acquired IV Hydreight, a mobile health and online pharmacy solution. IV Hydreight teamed up with VST subsidiary “Victory Square Health” to scale offerings in Brazil.
- Completed a C$6,000,000 sale of a virtual private network (VPN) to Cloud Nine Web3 Technologies.
- Signed a binding letter of intent (LOI) to invest in Stardust Solar, a renewable energy company.
- Successfully listed its subsidiary GameOn Entertainment Technologies on the Canadian Stock Exchange (CSE) under the symbol GET.
- Was featured in Forbes and the Entrepreneur & Worth publications.
“Over the past 48 months, the Company has teamed up with some of the brightest and forward thinking entrepreneurs from around the world. The success of many of the earlier invested companies resulted in VST posting record net income of just under $20M and positive earnings per share of $.30 for fiscal 2020. While 2020 represented an ‘Inflection Point’ in the Victory Square business model, 2021 can be labelled the “Harvest”. Following the successful spin-off of FansUnite in 2020, we’ve got GameOn, Immersive and potentially 3 more portfolio companies teed up to be spun off in the next 12 months. In addition, we’ve seen significant growth in 2021 from our other portfolio companies, including Covalent, Hydreight and the recent launch of DiscreetCare.com,” said Shafin Diamond Tejani Victory Square CEO.
Disclaimer: Victory Square Technologies is a communications client of Edge Investments, and we own shares in the company.